deferasirox has been researched along with Spherocytosis, Hereditary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihling, C; Tesch, H | 1 |
1 other study(ies) available for deferasirox and Spherocytosis, Hereditary
| Article | Year |
|---|---|
Loss of transfusion dependency following deferasirox treatment of iron overload in a woman with myelofibrosis and spherocytosis - a case report.
Topics: Aged; Benzoates; Blood Transfusion; Deferasirox; Female; Humans; Iron Chelating Agents; Iron Overload; Primary Myelofibrosis; Spherocytosis, Hereditary; Treatment Outcome; Triazoles | 2013 |